Co-founded by two Harvard-trained PhDs with over a decade of combined experience analyzing genomic data, Genterpret has set out to build the leading service to help researchers gain access to rich genetic and clinical datasets to drive research towards effective and safe treatments. Genterpret is based in Cambrdige, MA and is backed by Blueprint Health, a New York-based startup accelerator dedicated to enterprise healthcare solutions.